Yttrium Y90Ibritumomab Tiutexan (Zevalin)as a consolidation treatment for patients with high grade non-Hodgkin's lymphoma aged >60 years. - ND
- Conditions
- High grade B cell non-Hodgkin lymphoma.MedDRA version: 9.1Level: HLGTClassification code 10025320Term: Lymphomas non-Hodgkin's B-cell
- Registration Number
- EUCTR2008-003828-38-IT
- Lead Sponsor
- AZIENDA OSPEDALIERA OSPEDALE S. SALVATORE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Diagnosis of CD 20 positive B cell non-Hodgkin lymphoma.
Age > 60 years.
IPI>1.
Stage > II.
HIV negativity.
Signed informed consent.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Age < 60 years.
HIV positivity;
Intercurrent organ damage or medical conditions which possibly would interfere with therapy.
Concurrent infection not controlled by medical therapy.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method